CClinicalTrials.gg
Status unknownNCT02277652ETIDUpdated Nov 13, 2014

Endotracheal Intubation Devices

An interventional study of The Miller Laryngoscope and The Bonfils intubation fibrescope in Intubation, sponsored by International Institute of Rescue Research and Education. Status unknown at 1 site in Poland. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2014-11-13.

Sponsored by International Institute of Rescue Research and Education · Not applicable, Interventional, and Treatment

The sponsor has not verified this record recently (last verified Nov 2014), so the status shown — last known as Recruiting — may be out of date.
Phase
Not applicable
Study type
Interventional
Enrollment
120
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

The purpose of this study was to compare the four different intubation devices in 6 different scenarios.

02

Conditions studied

  • Intubation
03

In context

Lead sponsor

International Institute of Rescue Research and Education is the lead sponsor of 36 studies on the registry; none are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • give voluntary consent to participate in the study
  • minimum 1 year of work experience in emergency medicine
  • experienced emergency medical personnel (paramedics, nurses, physicians)

Exclusion criteria

Exclusion Criteria:

  • not meet the above criteria
  • wrist or low back diseases
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Crossover assignment
Masking
Single (Outcomes assessor)
Enrollment
120 participants (estimated)

Study arms

  • Experimental
    Scenario 1: Uninterrupted chest compressions

    Endotracheal intubation (ETI) during pediatric manikin with uninterrupted chest compressions. Chest compression was performed using LUCAS-2 (Physio-Control, USA).

    Device: The Miller Laryngoscope · Device: The Bonfils intubation fibrescope · Device: The GlideScope Ranger · Device: The Supraglottic Airway Laryngopharyngeal Tube (SALT)

  • Experimental
    Scenario 2: Neutral position

    ETI performed in neutral mannikin head position

    Device: The Miller Laryngoscope · Device: The Bonfils intubation fibrescope · Device: The GlideScope Ranger · Device: The Supraglottic Airway Laryngopharyngeal Tube (SALT)

  • Experimental
    Scenario 3: Sniffing position

    ETI performed in sniffing mannikin head position

    Device: The Miller Laryngoscope · Device: The Bonfils intubation fibrescope · Device: The GlideScope Ranger · Device: The Supraglottic Airway Laryngopharyngeal Tube (SALT)

  • Experimental
    Scenario 4: Pharyngeal swelling

    ETI performed during mannikin pharyngeal swelling scenario

    Device: The Miller Laryngoscope · Device: The Bonfils intubation fibrescope · Device: The GlideScope Ranger · Device: The Supraglottic Airway Laryngopharyngeal Tube (SALT)

  • Experimental
    Scenario 5: Swollen tongue

    ETI performed during mannikin swollen tongue scenario

    Device: The Miller Laryngoscope · Device: The Bonfils intubation fibrescope · Device: The GlideScope Ranger · Device: The Supraglottic Airway Laryngopharyngeal Tube (SALT)

  • Experimental
    Scenario 6: Immobilized cervical spine

    ETI performed during mannikin immobilized cervical spine scenario

    Device: The Miller Laryngoscope · Device: The Bonfils intubation fibrescope · Device: The GlideScope Ranger · Device: The Supraglottic Airway Laryngopharyngeal Tube (SALT)

Interventions

  • DeviceThe Miller Laryngoscope

    Direct laryngoscopy

  • DeviceThe Bonfils intubation fibrescope

    Optical laryngoscopy

  • DeviceThe GlideScope Ranger

    Videolaryngoscopy

  • DeviceThe Supraglottic Airway Laryngopharyngeal Tube (SALT)

    Blind intubation

06

What researchers measure

Primary outcomes

  1. Time to intubation

    time from insertion of the blade to the first manual ventilation of the manikin´s lungs. If time of intubation is over than 60 seconds, attempt was recognized as failure.

    Time frame: 1 month

Secondary outcomes

  1. Success of intubation

    effectiveness of the first, second and third intubation attempts and overall effectiveness of intubation by participants using four intubation devices. If the examinee failed at all attempts, the case was excluded from the time calculations.

    Time frame: 1 month

  2. POGO score

    self-reported percentage of glottis opening (POGO) score

    Time frame: 1 month

  3. VAS score

    participants were asked which method they would prefer in a real-life resuscitation.

    Time frame: 1 month

  4. Cormack-Lehane grading

    self-reported percentage the vocal cord visualization using the Cormack-Lehane grading (grade 1-4)

    Time frame: 1 month

07

Study locations

1 of 1 sites recruiting
  • International Institute of Rescue Research and Education
    Warsaw, Masovia 03-122, Poland
    Recruiting
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Nov 13, 2014, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT02277652
Lead sponsor
International Institute of Rescue Research and Education
Responsible party
Lukasz Szarpak (Lukasz Szarpak, National Institute of Cardiology, Warsaw, Poland) — Principal investigator
First posted
Oct 29, 2014
Start date
Oct 2014
Primary completion
Nov 2014 (estimated)
Completion
Nov 2014 (estimated)
Last update
Nov 13, 2014

Study contacts

Lukasz Szarpak
Contact
lukasz.szarpak@gmail.com
(+48)500186225
Lukasz Szarpak
principal investigator · National Institute of Cardiology, Warsaw, Poland
Andrzej Kurowski
principal investigator · National Institute of Cardiology, Warsaw, Poland

Oversight

Data monitoring committee
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Nov 2014. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion